The Buyback Debate and What the Numbers Actually Show

Few practices in corporate finance attract as much political heat as the stock buyback, and few are as poorly understood by the people heated about it. The buyback — a company using its cash to repurchase its own shares — is praised by some as a disciplined return of capital and condemned by others as a financial manipulation that inflates executive compensation at the expense of investment. The data, examined carefully, is beginning to clarify what buybacks actually do, and the clarification is less satisfying than either side's slogans.

The first thing the data shows is that buybacks are not, in the aggregate, the enemy of investment their critics describe. Companies that buy back stock also invest, and the firms doing the most repurchasing are often the firms with the most cash and the strongest cash flow. The choice between investing and returning capital is real at the margin, but it is not the either-or the political rhetoric assumes.

What a buyback actually does

A buyback reduces the number of shares outstanding, which increases earnings per share for the remaining shares. This is mechanical, and it is the basis of the manipulation charge: a company can improve its EPS, and thus the metrics on which its executives are compensated, without improving the underlying business. The charge contains a kernel of truth. EPS does rise when shares are repurchased, and a compensation plan tied to EPS will reward executives for the repurchase regardless of whether the underlying earnings improved.

But the manipulation critique oversimplifies what is happening. A buyback returns cash to shareholders who choose to sell, and the company gives up that cash in exchange for the shares. The shareholders who keep their stock hold a larger claim on a company with less cash, and whether they are better off depends on what the company would have done with the cash instead. If the alternative was a value-destroying acquisition or a low-return investment, the buyback was the better use. If the alternative was a high-return investment the company passed up, the buyback destroyed value. The judgment depends on the alternatives, not on the buyback itself.

The investment tradeoff, examined

The most serious charge against buybacks is that they crowd out productive investment — that companies are returning cash to shareholders rather than investing in the research, capacity and workers that would grow the business and the economy. The data on this question is more nuanced than the charge suggests. Aggregate investment as a share of cash flow has not collapsed alongside the rise of buybacks; if anything, the firms doing the most repurchasing tend to be mature, cash-generative businesses whose investment opportunities are limited relative to their cash generation.

What the data does not resolve is whether these firms are underinvesting relative to some longer-term potential. A company that buys back stock because its near-term projects do not meet its hurdle rate may be passing up investments whose returns are lower but whose strategic value is higher. The accounting captures the projects that are funded; it does not capture the projects that were never proposed because the cash was earmarked for repurchase. This is the version of the critique the data cannot settle, and it is the version the critics should be making.

The compensation problem

Where the critics have the stronger case is on executive compensation. Buybacks raise EPS, and EPS is a common metric in executive pay, which means executives have a personal incentive to repurchase stock even when the repurchase is not the best use of capital. This is a governance problem more than a finance problem, and it is soluble by better compensation design — tying pay to metrics buybacks cannot mechanically improve, or requiring that repurchases be net of new share issuance rather than gross.

The companies that have addressed this have done so under pressure from shareholders who recognize the conflict, not from regulators. Whether the broader market adopts better practice depends on whether institutional investors push for it, and the early evidence is that some are beginning to.

What the data is settling and what it is not

The picture the data is settling on is a middle position the slogans cannot accommodate. Buybacks are not, in general, value-destroying; they are a legitimate way to return cash when the company lacks better uses for it. They are not, in general, harmless; they can be used to inflate metrics that drive compensation, and they can be a substitute for investment whose absence shows up only over time. Whether a given buyback was good or bad depends on the alternatives the company faced, and the aggregate statistics cannot tell us which companies made the right call.

This is an unsatisfying conclusion for a debate that prefers villains and heroes, but it is the conclusion the evidence supports. The policy question is not whether to ban buybacks — a ban would push the same activity into less transparent forms — but how to align the incentives of executives with the long-term interests of the companies they run. The data cannot design that alignment, but it can tell us when the incentives are misaligned, and the buyback is one of the places they most often are.